
Rice University has found its inaugural vice-president for innovation in Paul Cherukuri, currently executive director of its Institute of Biosciences and Bioengineering.
These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Mary Albertson is the new director for Georgia Techās Office of Technology Licensing, joining from University of Utahās Pivot Center.
Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
The new Berkeley Frontier Fund reinvents the venture capital model by building in donations to University of California, Berkeley.
Bin Yan will become associate vice-president for research and director of the Office of Technology Management in September.
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Regis Kelly, executive director of University of Californiaās QB3 is retiring after more than 50 years with the institution.
Alastair Hick spent, up until now senior director of Monash Innovation, will serve as the universityās inaugural chief commercialisation officer.
These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.
Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.